Table 4.

The association between unawareness to pharmacokinetics and pharmacodynamics to dispensing and prescribing melatonin.

Variable	Dispensing or Prescribing Melatonin	Not Dispensing Nor Prescribing Melatonin	p-Value
Reported unawareness on pharmacokinetics n = 185	156 (84.3%)	29 (15.7%)	<0.001 *
Reported unawareness of pharmacodynamics n = 190	161 (84.7%)	29 (15.3%)	<0.001 *
Reported adverse drug reactions over the last three months n = 23	23 (100%)	0	0.067

* Presents a significant difference in the chi-square test.